How pharma can help the NHS deliver personalised care
Conversation around healthcare is still dominated by NHS waiting lists and challenges with workforce capacity. Indeed, both those in the NHS and the healthcare industry are scouring for strategies that not only maximise resources but also improve patient outcomes.
Now, more than ever, long-term conditions demand our focus in order to generate the innovations that can, in turn, help the NHS.
In the recent National GP Patient Survey, 56% of patients have a long-term condition – the highest level for six years, with more than one in five not feeling confident enough to manage their condition. Meanwhile, Age UK’s recent figures suggest that by 2040 in England, we will have over nine million people with a major illness.
Check out the rest of this feature here